Is the GLP-1 Molecule Causing Hair Loss?
Patients opening Reddit or TikTok are often terrified by reports of massive hair shedding on Semaglutide or Tirzepatide.
However, extensive clinical trial data (including the STEP and SURPASS trials) demonstrates that GLP-1 receptor agonists do not possess direct follicular cytotoxicity. The medication itself does not attack your hair roots.
Instead, the culprit is a well-documented physiological phenomenon known as Telogen Effluvium (TE).
---
What is Telogen Effluvium?
Your hair follicles cycle through three phases: 1. Anagen (Growth Phase): 85% to 90% of follicles are actively growing, lasting 2 to 6 years. 2. Catagen (Transition Phase): 1% to 2% of follicles undergo involution over 2 to 3 weeks. 3. Telogen (Resting & Shedding Phase): 10% to 15% of follicles rest before shedding.
When the body undergoes a profound metabolic stressor — such as losing 15 to 25 pounds in 8 weeks, severe food apathy, or dropping below 900 calories a day — the brain interprets this as a famine state.
The Biological Triage Effect
The body immediately executes metabolic triage: - Non-essential structures (hair follicles, nail beds, dermal collagen) have their cellular energy cut. - Essential viscera (heart muscle, brain, liver, renal filtration) receive prioritized amino acid distribution.As a result, up to 30% to 50% of growing anagen hairs prematurely shift into the telogen resting phase. Approximately 2 to 3 months later, these hairs shed simultaneously during washing and brushing.
---
